The US FDA proposes to switch to annual vaccinations against COVID

23 Jan. (Reuters) – The US health regulator on Monday proposed a dose of the latest updated COVID-19 shot per year for healthy adults similar to the flu vaccination campaign as it aims to simplify the country’s COVID vaccination strategy.

The U.S. Food and Drug Administration has also asked its panel of outside advisors to consider using two COVID vaccine injections per year for some young children, older adults and individuals with compromised immunity. vaccine, similar to how strains for flu vaccines are changed annually, in briefing papers ahead of a panel meeting on Thursday.

The FDA hopes that annual immunization schedules can contribute to less complicated vaccine deployment and fewer errors in vaccine administration, leading to better vaccine coverage.

A nurse fills syringes with the coronavirus disease (COVID-19) vaccines for residents over the age of 50 who are immunocompromised and eligible for their second booster injections in Waterford, Michigan, U.S., April 8, 2022. REUTERS/Emily Elconin

The Biden administration has also planned a campaign of vaccine boosters for each fall season.

Currently, most people in the United States must first receive two doses of the original COVID vaccine at least three to four weeks apart, depending on the vaccine, followed by a booster dose a few months later.

Pfizer’s primary vaccine doses for children and humans include three injections, with the third a bivalent injection about two months later.

If the panel votes in favor of the proposal, the bivalent vaccines from Pfizer Inc (PFE.N) and Moderna Inc (MRNA.O), targeting both the Omicron and original variants, would be used for all COVID vaccine doses, and not just as boosters.

Reporting by Leroy Leo in Bengaluru; Edited by Shailesh Kuber and Shinjini Ganguli

Our Standards: The Thomson Reuters Principles of Trust.

Leave a Comment